In a recent trial marijuana was shown to induce ‘complete remission’ for patients suffering from the condition, which is also known as inflammatory bowel disease.
Scientists at Meir Medical Center, Israel, studied 21 people with severe Crohn’s disease who did not respond to various therapies.
A ‘complete remission’ of Crohn’s disease was recorded in 5/11 (45%) of the cannabis group and 1/10 in the placebo group.
A total of 10/11 patients in the cannabis group responded to the clinical trial with Crohn’s symptoms (which include pain, diarrhoea, tiredness and weight loss) significantly reduced.
In addition, study authors wrote: “Subjects receiving cannabis reported improved appetite and sleep, with no significant side effects.”
“Further studies, with larger patient groups and a non-smoking mode of intake, are warranted,”